RGC vs. MSTY

Last updated Apr 1, 2026

Compare and contrast key facts about Regencell Bioscience Holdings Limited (RGC) and YieldMax™ MSTR Option Income Strategy ETF (MSTY).

MSTY is an actively managed fund by YieldMax. It was launched on Feb 21, 2024.

Performance

RGC vs. MSTY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Regencell Bioscience Holdings Limited (RGC) and YieldMax™ MSTR Option Income Strategy ETF (MSTY). The values are adjusted to include any dividend payments, if applicable.

RGC vs. MSTY - Yearly Performance Comparison

	2026 (YTD)	2025	2024
RGC Regencell Bioscience Holdings Limited	21.10%	16,053.85%	-34.74%
MSTY YieldMax™ MSTR Option Income Strategy ETF	-13.58%	-42.71%	200.20%

Returns By Period

In the year-to-date period, RGC achieves a 21.10% return, which is significantly higher than MSTY's -13.58% return.

RGC

• 1D: 9.00%
• 1M: -3.05%
• YTD: 21.10%
• 6M: 64.60%
• 1Y: 2,931.18%
• 3Y*: 234.24%
• 5Y*: —
• 10Y*: —

MSTY

• 1D: 2.45%
• 1M: -1.67%
• YTD: -13.58%
• 6M: -54.23%
• 1Y: -48.88%
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

RGC vs. MSTY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RGC

RGC Risk / Return Rank: 99
RGC Sharpe Ratio Rank: 100
RGC Sortino Ratio Rank: 99
RGC Omega Ratio Rank: 99
RGC Calmar Ratio Rank: 100
RGC Martin Ratio Rank: 100

MSTY

MSTY Risk / Return Rank: 2
MSTY Sharpe Ratio Rank: 2
MSTY Sortino Ratio Rank: 2
MSTY Omega Ratio Rank: 2
MSTY Calmar Ratio Rank: 2
MSTY Martin Ratio Rank: 3

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

RGC vs. MSTY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Regencell Bioscience Holdings Limited (RGC) and YieldMax™ MSTR Option Income Strategy ETF (MSTY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	RGC	MSTY	Difference
Sharpe ratio Return per unit of total volatility	7.76	-0.77	+8.52
Sortino ratio Return per unit of downside risk	6.67	-1.05	+7.72
Omega ratio Gain probability vs. loss probability	1.84	0.88	+0.97
Calmar ratio Return relative to maximum drawdown	42.26	-0.68	+42.94
Martin ratio Return relative to average drawdown	54.68	-1.22	+55.90
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

RGC vs. MSTY - Sharpe Ratio Comparison

The current RGC Sharpe Ratio is 7.76, which is higher than the MSTY Sharpe Ratio of -0.77. The chart below compares the historical Sharpe Ratios of RGC and MSTY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	RGC	MSTY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	7.76	-0.77	+8.52
Sharpe Ratio (All Time) Calculated using the full available price history	0.52	0.29	+0.23

Correlation

The correlation between RGC and MSTY is -0.02. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.

Dividends

RGC vs. MSTY - Dividend Comparison

RGC has not paid dividends to shareholders, while MSTY's dividend yield for the trailing twelve months is around 298.73%.

	TTM	2025	2024
RGC Regencell Bioscience Holdings Limited	0.00%	0.00%	0.00%
MSTY YieldMax™ MSTR Option Income Strategy ETF	298.73%	294.61%	104.56%

Drawdowns

RGC vs. MSTY - Drawdown Comparison

The maximum RGC drawdown since its inception was -93.09%, which is greater than MSTY's maximum drawdown of -71.79%. Use the drawdown chart below to compare losses from any high point for RGC and MSTY.

Drawdown Indicators

	RGC	MSTY	Difference
Max Drawdown Largest peak-to-trough decline	-93.09%	-71.79%	-21.30%
Max Drawdown (1Y) Largest decline over 1 year	-86.72%	-71.79%	-14.93%
Current Drawdown Current decline from peak	-67.40%	-66.02%	-1.38%
Average Drawdown Average peak-to-trough decline	-59.11%	-23.37%	-35.74%
Ulcer Index Depth and duration of drawdowns from previous peaks	67.02%	40.02%	+27.00%

Volatility

RGC vs. MSTY - Volatility Comparison

Regencell Bioscience Holdings Limited (RGC) has a higher volatility of 28.69% compared to YieldMax™ MSTR Option Income Strategy ETF (MSTY) at 14.90%. This indicates that RGC's price experiences larger fluctuations and is considered to be riskier than MSTY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	RGC	MSTY	Difference
Volatility (1M) Calculated over the trailing 1-month period	28.69%	14.90%	+13.79%
Volatility (6M) Calculated over the trailing 6-month period	108.39%	48.86%	+59.53%
Volatility (1Y) Calculated over the trailing 1-year period	383.81%	63.88%	+319.93%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	313.90%	72.67%	+241.23%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	313.90%	72.67%	+241.23%